Atlas Trials

Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion

Clinical trial NCT05693727 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05693727
Sponsor
Assiut University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Pleural Effusion, Malignant
Start date
2023-09-01
Primary completion
2026-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.